PM Narendra Modi Meet With 3 teams involved in making COVID-19 vaccine

Covid-19 vaccine development: Prime Minister Narendra Modi (PM Modi) will speak on Monday with three teams engaged in developing vaccines (Coronavirus Vaccine) to protect against coronavirus. Through video conferencing, the Prime Minister will seek information from Genova Biopharma, Biological E and Dr. Reddy’s team on the development of Covid-19 vaccine development.


Read More – Long Distance relationships in Covid 19 time
PM Narendra Modi to interact with 3 teams involved in developing Covid vaccine - The Economic TimesPrime Minister’s Office tweeted, “Prime Minister Narendra Modi tomorrow, 30 In November 2020, through a video conference, Kovid will interact with the three teams involved in developing the 19 vaccine. Teams with whom the Prime Minister will be talking include Genoa Biopharma, Biological E and Dr. Reddy’s team. Also Read – Haryana Health Minister Anil Vij said, doctors told me about the efficiency of covaxin.


https://www.youtube.com/watch?v=pPxeAmCn8xI

Also Read – In corona infected The risk of this dreaded disease increases, immunity may be weakened, it can be killedTomorrow, on 30th November 2020, PM @narendramodi will interact, via video conferencing, with three teams that are involved in developing a COVID-19 vaccine. The teams he will interact with are from Gennova Biopharma, Biological E and Dr. Reddy’s.
– PMO India (@PMOIndia) November 29, 2020

Coronavirus vaccine news updates: India says local Covid-19 vaccine final trials could end within two months | Deccan Herald

Earlier, Prime Minister Narendra Modi (PM Modi) visited three cities on Saturday and visited Corona vaccines in the institutions there. Progress was made to make (Corona vaccine). Prime Minister Modi visited Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad and Serum Institute of India in Pune. During this time, the Prime Minister expressed pride that the progress in indigenous vaccines being developed in India has been very good so far. He also sought suggestions on how to further improve the delivery of vaccines.

Be the first to comment

Leave a Reply

Your email address will not be published.


*